Detalhe da pesquisa
1.
Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank.
Am J Hum Genet
; 110(4): 648-662, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977412
2.
Germline MBD4 deficiency causes a multi-tumor predisposition syndrome.
Am J Hum Genet
; 109(5): 953-960, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460607
3.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
4.
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2.
Genet Med
; 26(5): 101101, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362852
5.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571512
6.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
7.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897700
8.
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer.
Eur J Epidemiol
; 38(10): 1053-1068, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789226
9.
Genetic testing for hereditary breast cancer in Poland: 1998-2022.
Hered Cancer Clin Pract
; 21(1): 9, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312208
10.
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.
Breast Cancer Res
; 24(1): 69, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271417
11.
The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Br J Cancer
; 127(1): 84-91, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256754
12.
Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer.
Mol Genet Genomics
; 297(4): 965-979, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562597
13.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
14.
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.
J Med Genet
; 58(5): 305-313, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546565
15.
Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.
Hered Cancer Clin Pract
; 20(1): 1, 2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983599
16.
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland.
Hered Cancer Clin Pract
; 20(1): 13, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395863
17.
Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland.
Hered Cancer Clin Pract
; 20(1): 12, 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382848
18.
Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.
Hered Cancer Clin Pract
; 20(1): 11, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313928
19.
Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer.
Int J Mol Sci
; 23(3)2022 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163215
20.
PALB2 mutations and prostate cancer risk and survival.
Br J Cancer
; 125(4): 569-575, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006922